6:17 PM
 | 
Jan 17, 2014
 |  BC Extra  |  Company News

Astellas' ipragliflozin approved in Japan

Astellas Pharma Inc. (Tokyo:4503) said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for Suglat ipragliflozin to...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >